Silvercrest Asset Management Group LLC boosted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 45,630 shares of the medical research company’s stock after buying an additional 1,053 shares during the period. Silvercrest Asset Management Group LLC’s holdings in Thermo Fisher Scientific were worth $26,521,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of TMO. LifeSteps Financial Inc. purchased a new stake in Thermo Fisher Scientific in the first quarter valued at approximately $31,000. Northwest Financial Advisors purchased a new stake in shares of Thermo Fisher Scientific in the 4th quarter valued at $29,000. True Wealth Design LLC grew its position in Thermo Fisher Scientific by 1,275.0% in the 4th quarter. True Wealth Design LLC now owns 55 shares of the medical research company’s stock valued at $29,000 after acquiring an additional 51 shares in the last quarter. Headlands Technologies LLC acquired a new stake in shares of Thermo Fisher Scientific during the first quarter worth about $32,000. Finally, Pineridge Advisors LLC purchased a new stake in Thermo Fisher Scientific during the 4th quarter worth approximately $39,000. Hedge funds and other institutional investors own 89.23% of the company’s stock.
Insider Transactions at Thermo Fisher Scientific
In related news, SVP Michael A. Boxer sold 2,000 shares of Thermo Fisher Scientific stock in a transaction on Friday, July 26th. The shares were sold at an average price of $600.85, for a total value of $1,201,700.00. Following the transaction, the senior vice president now directly owns 13,083 shares in the company, valued at approximately $7,860,920.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CEO Marc N. Casper sold 10,000 shares of the firm’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $567.28, for a total value of $5,672,800.00. Following the completion of the sale, the chief executive officer now owns 123,816 shares in the company, valued at $70,238,340.48. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Michael A. Boxer sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $600.85, for a total value of $1,201,700.00. Following the transaction, the senior vice president now owns 13,083 shares in the company, valued at approximately $7,860,920.55. The disclosure for this sale can be found here. Insiders sold 16,784 shares of company stock worth $9,801,825 over the last 90 days. 0.34% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on Thermo Fisher Scientific
Thermo Fisher Scientific Stock Performance
TMO traded up $3.51 during trading on Tuesday, hitting $607.63. 599,583 shares of the stock were exchanged, compared to its average volume of 1,558,115. The firm has a market capitalization of $231.94 billion, a P/E ratio of 39.13, a PEG ratio of 2.83 and a beta of 0.77. Thermo Fisher Scientific Inc. has a 1-year low of $415.60 and a 1-year high of $614.79. The stock has a fifty day moving average price of $563.21 and a two-hundred day moving average price of $566.38. The company has a quick ratio of 1.37, a current ratio of 1.72 and a debt-to-equity ratio of 0.64.
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) last released its quarterly earnings results on Wednesday, July 24th. The medical research company reported $5.37 EPS for the quarter, beating the consensus estimate of $5.13 by $0.24. The firm had revenue of $10.54 billion during the quarter, compared to the consensus estimate of $10.50 billion. Thermo Fisher Scientific had a net margin of 14.69% and a return on equity of 18.22%. Thermo Fisher Scientific’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.15 EPS. As a group, sell-side analysts predict that Thermo Fisher Scientific Inc. will post 21.69 earnings per share for the current year.
Thermo Fisher Scientific Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Friday, September 13th will be paid a $0.39 dividend. The ex-dividend date is Friday, September 13th. This represents a $1.56 annualized dividend and a dividend yield of 0.26%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 10.01%.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Further Reading
- Five stocks we like better than Thermo Fisher Scientific
- High Dividend REITs: Are They an Ideal Way to Diversify?
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- What is Insider Trading? What You Can Learn from Insider Trading
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.